Memphis-based NovaLign Orthopedics received FDA "fast-track" 510(k) clearance to sell a new trauma surgery product, according to a report in the Memphis Commercial Appeal.
The new product is a type of intramedullary nail, which is a rod that is inserted into a badly broken bone to keep the fragments together, according to the report.
The FDA clearance means that the agency feels that this device is similar to other products on the market and does not require clinical trials.
Read the Commercial Appeal’s report about NovaLign’s new intramedullary nail.
Watertown, N.Y.-based Samaritan Medical Center has selected Kopp Billing Agency to manage its patient billing services, effective May 1. The…
Across the U.S., maternity services at hospitals, particularly in rural areas, are disappearing at an alarming rate. Over the last…
Ambience Healthcare and Houston Methodist have launched a collaboration to bring AI to emergency departments and inpatient care, aiming to…
Comments are closed.
